In the early days of 2020, a wave of fear gripped countless individuals seeking medical help. Patients arrived at Dr. Peter McCullough’s practice, battling illness and overwhelmed with anxiety, only to be met with a disheartening directive: return home, wait, and hope for improvement. Dr. McCullough refused to passively accept this approach.
While many in the medical community adhered to established protocols, he embarked on a relentless pursuit of solutions. He meticulously reviewed research, engaged in discussions with international colleagues, and utilized every available therapeutic option for his patients. His investigation revealed a truth that powerful entities sought to suppress.
Ivermectin, a medication already decades old, wasn’t a novel or experimental treatment. It wasn’t concocted in a makeshift laboratory, but a globally recognized drug, awarded the Nobel Prize in Medicine for its remarkable effectiveness against parasitic infections and various debilitating conditions.
Dr. McCullough recognized its potential and shared this knowledge with those under his care. This act of medical integrity, however, came at a steep price. He faced intense criticism, professional attacks, and formal investigations, yet he remained steadfast in his commitment to truth.
The core issue, often overlooked, lies in the global supply chain of ivermectin. A staggering 75% of the world’s supply originates in Asia. Ordering from many online sources means uncertainty – a lack of transparency regarding manufacturing processes, quality control, and the actual contents of each capsule.
This represents a significant risk, placing your health and the well-being of your family in the hands of an opaque and potentially unreliable system. Trusting an unknown source with such a vital medication is a gamble few can afford to take.
Recognizing this vulnerability, a dedicated effort was undertaken to secure a domestic source of ivermectin. This wasn’t simply repackaging or distribution; it was full-scale manufacturing within the United States, adhering to rigorous American quality standards and accountability measures.
A bottle of this domestically produced ivermectin offers complete assurance – you know precisely what you are receiving and its origin. This transparency provides peace of mind, a critical element when considering any medication.
Despite the expectation of a premium price for American-made quality, a different reality emerged. Conventional pharmacies often charge $5 or more per tablet, frequently offering lower-dose formulations that raise questions about efficacy.
A more compelling option is available: 18mg capsules, a higher and potentially more effective dose, offered at just $3.57 per tablet. This isn’t merely a cost savings; it’s a superior product at a lower price point.
A single order provides 84 capsules, a six-month supply designed around four 21-day cycles with 14-day breaks. This streamlined approach simplifies preventative care, offering two annual refills for consistent support.
Dr. McCullough’s journey wasn’t about seeking conflict, but about relentlessly pursuing answers for his patients, his family, and the wider community. This commitment fueled the creation of a company dedicated to providing safe, effective, and affordable medicine, free from systemic obstacles.
The availability of American-made ivermectin is inherently limited by the smaller number of domestic manufacturers. When quality and affordability converge, proactive action is essential. Securing a supply now ensures access to a vital resource when you need it most.
